<p><i>*p<0</i>.<i>05</i>, <i>**p<0</i>.<i>01</i>, <i>***p<0</i>.<i>001</i> vs. SHC; <i>###p<0</i>.<i>001</i> vs. SHADR; <i>$ $ $p<0</i>.<i>001</i> vs. SHADR+L; k- kidney; Data represent mean ± SEM; n = 6 rats in each group; SHC—control group, SHADR–SHR treated with adriamycin, L—losartan, T–tempol.</p
<p>(a) Serum Cr concentration. (b) Serum P concentration. (c) Serum Ca concentration. (d) <i>αKlotho...
<p>(A) Experimental design. (B–D) Comparison of rats that had anti-Thy1.1-nephritis and received H-M...
<p><i>*p<0</i>.<i>05</i>, <i>**p<0</i>.<i>01</i>, <i>***p<0</i>.<i>001</i> vs. SHC; <i>#p<0</i>.<i>0...
<p>(A) Representative micrographs of NOX2 immunostaining in SHAM operation, MVs and VEHICLE rats at ...
<p>(A) Chart showing the most expressive metalloproteinase; (B) ELISA MMP panel (<i>R&D Systems</i>)...
<p>(A) Representative zymographs and Western blots of L-MMP-9, A-MMP-9, L-MMP-2, A-MMP-2 and L-MMP-1...
<p>Data are means ± SE. *P<0.05, **P<0.01, ***P<0.001 VS CTL group, #P<0.05, ##P<0.01, ###P<0.001 VS...
<p>Kidneys from four experimental groups were collected for immunostaining and real-time PCR. <b>A.<...
<p>Myofibroblast number as indicated by α-SMA staining. Representative sections of glomeruli (400x) ...
<p>(A) Representative photomicrographs of Nox1 -immunoreactivity in the SN sections. AAV2 particles ...
<p>Shown: AQP2 protein abundance in IM tip and base tissue of control rats (<i>Ctrl</i>; white bars)...
<div><p>(A–D) In situ zymography. In situ zymography displayed gelatin-degrading activity in normal ...
*<p>p<0.01, **p<0.001 <i>versus</i> control group. +p<0.01, ++p<0.001 <i>versus</i> Cispt3.5 group. ...
indices were assessed. Results: The NX-AM group showed a significant decrease in all investigated pa...
<p>(A) The upper panels show representative blots from control and lipopolysaccharide (LPS)-treated ...
<p>(a) Serum Cr concentration. (b) Serum P concentration. (c) Serum Ca concentration. (d) <i>αKlotho...
<p>(A) Experimental design. (B–D) Comparison of rats that had anti-Thy1.1-nephritis and received H-M...
<p><i>*p<0</i>.<i>05</i>, <i>**p<0</i>.<i>01</i>, <i>***p<0</i>.<i>001</i> vs. SHC; <i>#p<0</i>.<i>0...
<p>(A) Representative micrographs of NOX2 immunostaining in SHAM operation, MVs and VEHICLE rats at ...
<p>(A) Chart showing the most expressive metalloproteinase; (B) ELISA MMP panel (<i>R&D Systems</i>)...
<p>(A) Representative zymographs and Western blots of L-MMP-9, A-MMP-9, L-MMP-2, A-MMP-2 and L-MMP-1...
<p>Data are means ± SE. *P<0.05, **P<0.01, ***P<0.001 VS CTL group, #P<0.05, ##P<0.01, ###P<0.001 VS...
<p>Kidneys from four experimental groups were collected for immunostaining and real-time PCR. <b>A.<...
<p>Myofibroblast number as indicated by α-SMA staining. Representative sections of glomeruli (400x) ...
<p>(A) Representative photomicrographs of Nox1 -immunoreactivity in the SN sections. AAV2 particles ...
<p>Shown: AQP2 protein abundance in IM tip and base tissue of control rats (<i>Ctrl</i>; white bars)...
<div><p>(A–D) In situ zymography. In situ zymography displayed gelatin-degrading activity in normal ...
*<p>p<0.01, **p<0.001 <i>versus</i> control group. +p<0.01, ++p<0.001 <i>versus</i> Cispt3.5 group. ...
indices were assessed. Results: The NX-AM group showed a significant decrease in all investigated pa...
<p>(A) The upper panels show representative blots from control and lipopolysaccharide (LPS)-treated ...
<p>(a) Serum Cr concentration. (b) Serum P concentration. (c) Serum Ca concentration. (d) <i>αKlotho...
<p>(A) Experimental design. (B–D) Comparison of rats that had anti-Thy1.1-nephritis and received H-M...
<p><i>*p<0</i>.<i>05</i>, <i>**p<0</i>.<i>01</i>, <i>***p<0</i>.<i>001</i> vs. SHC; <i>#p<0</i>.<i>0...